Market Overview:
The global serotonin syndrome treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of serotonin syndrome, rising awareness about the condition, and growing demand for better treatment options. The global serotonin syndrome treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into serotonin antagonists, supportive care, gastrointestinal decontamination, and other treatments. Serotonin antagonists are further sub-segmented into selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), and others. Supportive care includes therapies such as oxygen therapy, hydration therapy,, and others. Gastrointestinal decontamination includes methods such as activated charcoal administration,, nasogastric lavage,, ileus management,, and others). Other treatments include drugs such as benzodiazepines,. On the basis of application,. Hospital use accounts for majority share in terms of revenue in 2017 owing to high prevalence rateof serotonin syndrome in hospitals. Clinic use held second largest share in 2017 due to increasing numberof clinics offering serotonergic drug overdose management services. Geographically,. North America accounted for majority share in terms of revenue followed by Europeand Asia Pacificin 2017.
Product Definition:
Serotonin Syndrome Treatment is the process of managing and recovering from a serotonin syndrome. Serotonin Syndrome Treatment is important because it can prevent serious health complications from developing.
Serotonin Antagonists:
The serotonin syndrome treatment market is expected to witness lucrative growth over the forecast period owing to increasing incidences of serotonin syndrome and its treatment options. According to a study published in NCBI, about 1 in every 100 patients receiving chemotherapy for cancer develop this condition. Increasing awareness levels among physicians and patients are anticipated to boost the demand for effective drugs which may lead to new product development.
Supportive Care:
Supportive care is medical treatment given to a patient who is unable to take medication for disease or condition. It includes providing vital nutrients, fluids, and oxygen as well as monitoring the vital signs of a patient. In some cases, supportive care may include surgical procedures or hospitalization depending on the severity of symptoms.
Application Insights:
The other application segment held the largest share of more than 60.0% in 2017. The other applications include forensic use, research studies and accidental exposure to drugs or chemicals that cause serotonin syndrome. Accidental drug or chemical intake is a major concern for patients as well as their families, thus leading to high demand for treatment options in this segment.
Clinic use was the second-largest application of SSRI treatment and accounted for 29% of total revenue in 2017 due to increasing awareness about available treatments and availability of trained personnel at clinics across countries such as India, China Japan etc.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the number of reported cases and favorable government initiatives. The U.S. is at the forefront of this region with respect to market growth, followed by Europe due to presence of large target population and well-established healthcare infrastructure within these regions.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing prevalence of serotonergic syndrome among patients from emerging countries such as China & India, along with growing awareness about its treatment options amongst physicians and patients worldwide; especially after approval for commercial use by regulatory agencies such as FDA (Food & Drug Administration) or EMEA (European Medicines Agency). Growing disposable income coupled with rising consumerism has also contributed significantly towards regional demand for supportive care products including dietary supplements that are likely boost overall revenue generation in near future.
Growth Factors:
- Increasing incidence of serotonin syndrome
- Growing awareness about serotonin syndrome and its treatment options
- Rising demand for novel serotonin syndrome therapies
- Availability of government funding for serotonin syndrome research and development
- Technological advancements in the field of serotonin syndrome treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Serotonin Syndrome Treatment Market Research Report
By Type
Serotonin Antagonists, Supportive Care, Gastrointestinal Decontamination, Other
By Application
Hospital Use, Clinic Use, Other
By Companies
AstraZeneca, Eli Lilly and Company, Forest Laboratories, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Sanofi S.A., Ciron Drugs & Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Serotonin Syndrome Treatment Market Report Segments:
The global Serotonin Syndrome Treatment market is segmented on the basis of:
Types
Serotonin Antagonists, Supportive Care, Gastrointestinal Decontamination, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Use, Clinic Use, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- Eli Lilly and Company
- Forest Laboratories
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Pfizer
- Sanofi S.A.
- Ciron Drugs & Pharmaceuticals
Highlights of The Serotonin Syndrome Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Serotonin Antagonists
- Supportive Care
- Gastrointestinal Decontamination
- Other
- By Application:
- Hospital Use
- Clinic Use
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Serotonin Syndrome Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no specific treatment for serotonin syndrome, but the individual may need to be monitored and treated symptomatically. Treatment may include supportive care, such as medication to relieve symptoms, rest, and counseling.
Some of the key players operating in the serotonin syndrome treatment market are AstraZeneca, Eli Lilly and Company, Forest Laboratories, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Sanofi S.A., Ciron Drugs & Pharmaceuticals.
The serotonin syndrome treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Serotonin Syndrome Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Serotonin Syndrome Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Serotonin Syndrome Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Serotonin Syndrome Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Serotonin Syndrome Treatment Market Size & Forecast, 2018-2028
4.5.1 Serotonin Syndrome Treatment Market Size and Y-o-Y Growth
4.5.2 Serotonin Syndrome Treatment Market Absolute $ Opportunity
Chapter 5 Global Serotonin Syndrome Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Serotonin Syndrome Treatment Market Size Forecast by Type
5.2.1 Serotonin Antagonists
5.2.2 Supportive Care
5.2.3 Gastrointestinal Decontamination
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Serotonin Syndrome Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Serotonin Syndrome Treatment Market Size Forecast by Applications
6.2.1 Hospital Use
6.2.2 Clinic Use
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Serotonin Syndrome Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Serotonin Syndrome Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Serotonin Syndrome Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Serotonin Syndrome Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Serotonin Syndrome Treatment Market Size Forecast by Type
9.6.1 Serotonin Antagonists
9.6.2 Supportive Care
9.6.3 Gastrointestinal Decontamination
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Serotonin Syndrome Treatment Market Size Forecast by Applications
9.10.1 Hospital Use
9.10.2 Clinic Use
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Serotonin Syndrome Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Serotonin Syndrome Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Serotonin Syndrome Treatment Market Size Forecast by Type
10.6.1 Serotonin Antagonists
10.6.2 Supportive Care
10.6.3 Gastrointestinal Decontamination
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Serotonin Syndrome Treatment Market Size Forecast by Applications
10.10.1 Hospital Use
10.10.2 Clinic Use
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Serotonin Syndrome Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Serotonin Syndrome Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Serotonin Syndrome Treatment Market Size Forecast by Type
11.6.1 Serotonin Antagonists
11.6.2 Supportive Care
11.6.3 Gastrointestinal Decontamination
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Serotonin Syndrome Treatment Market Size Forecast by Applications
11.10.1 Hospital Use
11.10.2 Clinic Use
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Serotonin Syndrome Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Serotonin Syndrome Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Serotonin Syndrome Treatment Market Size Forecast by Type
12.6.1 Serotonin Antagonists
12.6.2 Supportive Care
12.6.3 Gastrointestinal Decontamination
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Serotonin Syndrome Treatment Market Size Forecast by Applications
12.10.1 Hospital Use
12.10.2 Clinic Use
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Serotonin Syndrome Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Serotonin Syndrome Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Serotonin Syndrome Treatment Market Size Forecast by Type
13.6.1 Serotonin Antagonists
13.6.2 Supportive Care
13.6.3 Gastrointestinal Decontamination
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Serotonin Syndrome Treatment Market Size Forecast by Applications
13.10.1 Hospital Use
13.10.2 Clinic Use
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Serotonin Syndrome Treatment Market: Competitive Dashboard
14.2 Global Serotonin Syndrome Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca
14.3.2 Eli Lilly and Company
14.3.3 Forest Laboratories
14.3.4 GlaxoSmithKline
14.3.5 Johnson & Johnson
14.3.6 Merck
14.3.7 Pfizer
14.3.8 Sanofi S.A.
14.3.9 Ciron Drugs & Pharmaceuticals
